Furthermore, we have previously demonstrated that a more severe inflammation, seen as high levels of IL-6, is associated with lower expression of VPAC1 in PBMCs from patients with early arthritis and, conversely, with increased expression of VPAC2 [21]. This evidence concerns the gene IL6 and arthritic joint disease.